BLFS Oct 2024 35.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:29AM EDT. Market open.
| Previous close | 0.7000 |
| Open | 0.6000 |
| Bid | 0.0000 |
| Ask | 1.4500 |
| Strike | 35.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.6000 - 0.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | 16 |
GuruFocus.comInsider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
Todd Berard, Chief Marketing Officer of BioLife Solutions Inc (NASDAQ:BLFS), executed a sale of 10,000 shares of the company on June 14, 2024.
ZacksBioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.
PR NewswireBioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced the introduction of the CryoCase, an addition to its CellSeal product line.
© 2024 Yahoo. All rights reserved.